id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2002-E-0336-0001,FDA,FDA-2002-E-0336,Determination of Regulatory Review Period for Purposes of Patent Extension; SOLAGE,Notice,General Notice,2002-11-14T05:00:00Z,2002,11,2002-11-14T05:00:00Z,2003-01-14T04:59:59Z,2025-09-30T19:27:12Z,02-28885,0,0,09000064804a0ca4